Dr Mark Drummond
MB ChB, PhD, FRCPath
Haematologist
33 years of experience
Edinburgh, EH12 6UD
6 connections in healthcare
Skill endorsed
by Mr Andrew Renwick, Dr Neil McKay
33 years of experience
Edinburgh, EH12 6UD
6 connections in healthcare
Skill endorsed
by Mr Andrew Renwick, Dr Neil McKay
Areas of expertise
Contact
Book
About Dr Mark Drummond
Dr. Mark Drummond is an accomplished Consultant Haematologist (for 18 years) with extensive experience in managing a wide range of haematological conditions. His primary areas of interest include Myeloproliferative disorders and Myelodysplasia. He has a very large non-malignant general haematology practice also, and gets regular referrals from GPs and other specialities for investigation and treatment of blood abnormalities.
Dr. Drummond obtained his medical degree from the University of Glasgow in 1992. His training in haematology took place in both Scotland and New Zealand, where he gained invaluable expertise in the field. In 2004, he achieved a PhD in Chronic Leukaemia. Dr. Drummond reached the milestone of becoming a Consultant in 2006 and is currently based at the Beatson Cancer Centre & Gartnavel general Hospital in Glasgow.
Within his role, Dr. Drummond serves as the Lead Clinician for Blood Cancers in the West of Scotland. He plays a significant role in coordinating and leading various UK and International Clinical Trials.
Dr. Drummond's dedication to research and education is evident through his authorship of over 60 peer-reviewed publications, including two textbooks focused on Haematological diagnosis. His commitment to advancing the field of haematology ensures that patients receive the highest standard of care and access to the latest treatment options.
Dr. Drummond offers a wide range of haematological services, including blood clot or thrombosis tests, blood disorder tests, blood type or blood group tests, blood transfusions, coagulation assessments, and haematological oncology care. Patients under his care benefit from his wealth of knowledge and expertise in the management of blood-related conditions.
Areas of expertise
Click the bar to read reviews or skill endorsements
Registered with
General Medical Council
No. 3687657
The Royal College of Pathologists
No. 1002753X
Education
University of Glasgow
Medicine
Graduated 1992
Qualifications
MB ChB 1992 University of Glasgow
PhD 2004 University of Glasgow
FRCPath 2005 Royal College of Pathologists
Publications
Read publications and papers written by this specialist.
Languages spoken
- English
Consultation fees
- New appointment: £230
- Follow-up appointment: £140
Insurers
- Bupa Fee Assured
- Freedom Health Insurance
- Healix Health Services
- Bupa
- WPA
- Cigna
- AXA Health
- Allianz Worldwide Care
- Aviva Health
- Vitality
- Aetna
- Simply Health (Dental)
Location
All locations for Dr Mark Drummond
(538)
122 Corstorphine Road, Edinburgh, United Kingdom, EH12 6UD
Reviews
AI Review Summary
This summary was created by AI based on recent reviews
Dr Mark Drummond is professional and clear in his patient interactions, offering excellent and understanding explanations. He explains complex conditions, such as Chronic Lymphatic Leukaemia and PV, in an uncomplicated and understandable manner. Patients feel at ease, supported, and confident in his assessments, noting his thoroughness and willingness to answer questions. His expertise covers managing conditions like Polycythemia, Iron Deficiency Anaemia, and various blood cancers.
Always feel listened to and well-looked after by Mr Drummond - making you feel that your care and wellbeing is his top priority.
I had a follow up phone call with DR Drummond that was short and to the point, covering the issues I wished to discuss and allowing him to present his recommendations clearly
Dr Drummond was very professional and had an excellent manner. Very happy with my experience.
Dr. Drummond has been an excellent consultant over the last six or so years. Always professional and explains everything in a clear and concise manner which I readily understand. I could not have asked for a better Chronic Lymphatic Leukema Consultant. So pleased I chose him.
Always very clear in his explanations, and very professional
I had a short consultation with Dr Drummond about a fairly straightforward matter. He was welcoming, thorough and clear - he was also really kind. An excellent communicator who told me everything I needed to know and was patient with some additional questions. Grateful to have seen him.
I had a consultation with Dr Drummond for PV. He is extremely knowledgeable, easy to talk to, listens to what you have to say and is happy to answer all questions you invariably have. He explains things in an uncomplicated and understandable manner and you come away with a feeling of being well looked after.
A fairly short but informative meeting , easy to understand and precise with recommendations plus genuine interest and direction
Skill Endorsements
all round great opinion
24 Feb 2026
Mr Andrew Renwick
General SurgeonExpert Haematology Care
26 Jan 2024DM
Dr Neil McKay
Rheumatologist
Get to know Dr Mark Drummond
Most recent articles
Read articles from Dr Mark Drummond explaining process of procedures and other important things you should know before choosing your provider.
Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A
Chromothripsis, the process of catastrophic shattering and haphazard repair of chromosomes, is a common event in cancer. Whether chromothripsis might constitute an actionable molecular event amenable to therapeutic targeting remains an open question. We describe recurrent chromothripsis of chromosome 21 in a subset of patients in blast phase of a myeloproliferative neoplasm (BP-MPN), which alongside other structural variants leads to amplification of a region of chromosome 21 in ~25% of patients (chr21amp).
30 December 2023
researchgate.net
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis
Current therapies for myeloproliferative neoplasms (MPNs) improve symptoms but have limited effect on tumor size. In preclinical studies, tamoxifen restored normal apoptosis in mutated hematopoietic stem/progenitor cells (HSPCs). TAMARIN Phase-II, multicenter, single-arm clinical trial assessed tamoxifen’s safety and activity in patients with stable MPNs, no prior thrombotic events and mutated JAK2V617F, CALRins5 or CALRdel52 peripheral blood allele burden ≥20% (EudraCT 2015-005497-38).
30 November 2023
researchgate.net
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution
Understanding the genetic and nongenetic determinants of tumor protein 53 (TP53)-mutation-driven clonal evolution and subsequent transformation is a crucial step toward the design of rational therapeutic strategies. Here we carry out allelic resolution single-cell multi-omic analysis of hematopoietic stem/progenitor cells (HSPCs) from patients with a myeloproliferative neoplasm who transform to TP53-mutant secondary acute myeloid leukemia (sAML).
30 September 2023
researchgate.net
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
Purpose: Polycythemia vera (PV) is characterized by JAK/STAT activation, thrombotic/hemorrhagic events, systemic symptoms, and disease transformation. In high-risk PV, ruxolitinib controls blood counts and improves symptoms. Patients and methods: MAJIC-PV is a randomized phase II trial of ruxolitinib versus best available therapy (BAT) in patients resistant/intolerant to hydroxycarbamide (HC-INT/RES).
31 May 2023
researchgate.net
FAQ
What are Dr Mark Drummond's reviews like?
Dr Mark Drummond's overall patient rating is 5 out of 5 stars on Doctify. This is based on 27 reviews.
What languages does Dr Mark Drummond speak?
Dr Mark Drummond speaks English
Where is Dr Mark Drummond located?
Dr Mark Drummond primarily practices at Spire Murrayfield Hospital Edinburgh, located at 122 Corstorphine Road, Edinburgh, United Kingdom, EH12 6UD
See more locations
What are Dr Mark Drummond working hours?
Dr Mark Drummond is working Monday (17:30 - 20:00)
Find where Dr Mark Drummond operates today
Does Dr Mark Drummond accept new patients?
Dr Mark Drummond generally accepts new patients.
Get in touch with this specialist to enquire as a new patient